The Czech EATRIS Spotlight event took place in early June at the Kaiserštejn Palace in Prague, bringing together leading experts to support translational medicine and strengthen collaboration among research infrastructures in the Czech Republic and across Europe. The event welcomed approximately 100 participants, including scientists, clinicians, representatives of research organisations, public authorities, and European partners.
The full-day programme showcased achievements in Czech biomedical research and emphasised the role of EATRIS-CZ in bridging basic research and clinical practice. Participants discussed novel therapeutic approaches, advanced diagnostic methods, the use of multi-omics data, artificial intelligence, and shared research capacities to accelerate the development of innovative healthcare solutions.
“The Czech EATRIS Spotlight Programme Event demonstrated that Czech biomedicine has much to offer the world. Bringing together more than one hundred experts under one roof clearly shows the potential of networking across research institutions, hospitals, companies, and public administration. Our goal is to ensure that promising discoveries move from laboratories to patients as quickly as possible – and this is exactly what the infrastructure we are building within EATRIS-CZ is designed to achieve. Science progresses slowly without collaboration; EATRIS-CZ is a platform that helps accelerate this process,” said Marián Hajdúch, National Director of EATRIS-CZ, who opened the conference.
The programme also featured a presentation by Aleksi Šedo, NICR Director, entitled National Institute for Cancer Research: A Model of Collaboration Between Research Infrastructures Supporting Translational Cancer Research. In his talk, he highlighted the importance of coordinated collaboration among research infrastructures, academic institutions and clinical centres in accelerating the translation of scientific discoveries into improved cancer prevention, diagnosis and treatment.
Read more here.
